miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma

• Mingli Lv ,

  Contributed equally to this work with: Mingli Lv, Xiaoping Zhang, Maoquan Li, Quanchi Chen

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Xiaoping Zhang ,

  Contributed equally to this work with: Mingli Lv, Xiaoping Zhang, Maoquan Li, Quanchi Chen

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Maoquan Li ,

  Contributed equally to this work with: Mingli Lv, Xiaoping Zhang, Maoquan Li, Quanchi Chen

  Affiliation Department of Interventional Therapy, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Quanchi Chen ,

  Contributed equally to this work with: Mingli Lv, Xiaoping Zhang, Maoquan Li, Quanchi Chen

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Meng Ye,

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Wenqing Liang,

  Affiliation Department of Orthopaedics, Shaoxing People’s Hospital, Shaoxing, China

  ⨯
• Lanbao Ding,

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Haidong Cai,

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Da Fu,

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯
• Zhongwei Lv

  * E-mail: lvzhongweikxy@163.com

  Affiliation Department of Nuclear Medicine, Shanghai 10th People’s Hospital, School of Medicine, Tongji University, Shanghai, China

  ⨯